EU-Startups
Paris-based Phagos raises €25 million to create a sustainable alternative to antibiotics
Paris-based biotech company Phagos has raised €25 million in a Series A funding round co-led by CapAgro, Hoxton Ventures, CapHorn and Demeter, with additional participation from […]
